Stay updated on Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page.

Latest updates to the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedLocations were updated with new sites across multiple countries and US states, and several existing locations were removed.SummaryDifference2%

- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the ClinicalTrials.gov page.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page removed a government funding and operating status notice. This is a housekeeping update and does not affect the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check79 days agoChange DetectedThe screenshots show only minor cosmetic/UI adjustments (layout spacing, fonts, and collapsed sections) with no changes to core study content, eligibility criteria, locations, timelines, or endpoints. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check101 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference4%

- Check108 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page.